Insulin-like growth factor I and bone mineral density: Experience from animal models and human observational studies

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 18, Issue 3, 2004, Pages 423-435

  Rosen, Clifford J ^a  

^a ST JOSEPH HOSPITAL   (United States)

Author keywords

Bone mineral density; Bone remodelling; Genomic models; IGF I

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN C;

ANIMAL MODEL; BONE CELL; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; CELLULAR DISTRIBUTION; COHORT ANALYSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ENGINEERING; HIP FRACTURE; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUTAGENESIS; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW;

EID: 3342952130     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.02.007     Document Type: Article

References (64)

1. Salmon W.D. Daughaday W.H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro Journal of Laboratory and Clinical Medicone 49 1957 825-836
2. LeRoith D. Bondy C. Yakar S. et al. The somatomedin hypothesis: endocrine reviews Endocrine Review 22 2001 53-74
3. Rosen C.J. Pollak M. Circulating IGF-I: new perspectives for a new century Trends in Endocrinology and Metabolism 10 1999 136-141
4. Rosen C.J. Donahue L.R. Hunter S.J. Insulin-like growth factors and bone: the osteoporosis connection Proceedings of the Society of Experimental Biology and Medicine 206 1994 83-102
5. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocrine Review 21 2000 115-137
6. Udgawa N. Takahasi N. Jimi E. Osteoblasts/stromal cells stimulate osteoclast differentiation factor/RANKL but not mCSF Bone 25 1999 517-523
7. Rosen C.J. Donahue L.R. Insulin-like growth factors and bone: the osteoporosis connection revisited Proceedings of the Society of Experimental Biology and Medicine 219 1998 1-7
8. Zapf J. Froesch E.R. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role Hormone and Metabolic Research 24 2/3 Review 1986 121-130
9. Hayden J.M. Mohan S. Baylink D.J. The insulin-like growth factor system and the coupling of formation to resorption Bone 17 2 supplement 1995 93S-98S
10. Mochizuki H. Hakeda Y. Wakatsuki N. et al. Insulin-like growth factor-I supports formation and activation of osteoclasts Endocrinology 131 1992 1075-1080
11. Kasukawa Y. Stabnov L. Miyakoshi N. et al. Insulin-like growth factor I effect on the number of osteoblast progenitors is impaired in ovariectomized mice Journal of Bone and Mineral Research 17 2002 1579-1587
12. Rubin J. Ackert-Bicknell C.L. Zhu L. et al. IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand in vitro and OPG in vivo Journal of Clinical and Endocrinology Metabolism 87 2002 4273-4279
13. McCarthy T.L. Ji C. Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation Critical Review in Oral and Biological Medicine 11 2000 409-422
14. McCarthy T.L. Ji C. Shu H. et al. 17Beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures Journal of Biological Chemistry 272 1997 18132-18139
15. McCarthy T.L. Centrella M. Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone Endocrinology 124 1989 1247-1253
16. McCarthy T.L. Centrella M. Canalis E. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures Journal of Biological Chemistry 265 1990 15353-15356
17. Ernst M. Rodan G.A. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control Molecular Endocrinology 5 1991 1081-1089
18. Rosen C.J. Dimai H.P. Vereault D. et al. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities Bone 21 1997 217-223
19. Rosen C.J. Churchill G.A. Donahue L.R. et al. Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice Bone 27 2000 521-528
20. Rosen C.J. Wozney J.M. in: Wozney J.M. ed. Bone morphogenetic proteins 2nd edn 2002 9129-9191 Academic Press San Diego, CA
21. Kveiborg M. Flyvbjerg A. Eriksen E.F. Kassem M. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors Journal of Endocrinology 169 2001 549-561
22. Li X. Tomita M. Pilbeam C.C. et al. Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo Prostaglandins and Other Lipid Mediatiators 67 2002 173-180
23. Mohan S. Baylink D. IGF system components and their role in bone metabolism in: Rosenfeld R. Roberts C. eds. The IGF Systems 1999 457-496 Humana Press Totowa, NJ
24. Rubin J. Chung L.W.K. Fan X. et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis Prostate 2004 in press
25. Wuster C. Duckeck G. Ugurel A. et al. Bone mass of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters European Journal of Clinical Investigation 22 1992 336-370
26. Delmas P.D. Chatelain P. Malaval L. Bonne G. Serum bone GLA-protein in growth hormone deficient children Journal of Bone and Mineral Research 1 1986 333-338
27. Wuster C. Slenczka E. Ziegler R. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? German Klinische Wochenschrift 69 1991 769-773
28. Johansson A.G. Burman P. Westermark K. Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I Journal of Internal Medicine 232 1992 447-452
29. Langlois J.A. Rosen C.J. Visser M. et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study Journal of Clinical and Endocrinology Metabolism 83 1998 4257-4262
30. Bauer D.C. Rosen C.J. Cauley J. Cummings S.R. Low serum IGF-I but not IGFBP-3 predicts hip and spine fractures Bone supplement 1997 561
31. Delmas P. Eastell R. Garnero P. et al. The use of biochemical markers of bone turnover in osteoporosis Osteoporosis International 6 supplement 2000 S2-S17
32. Rosen T. Hansson T. Granhed H. et al. Reduced bone mineral content in adult patients with growth hormone deficiency Acta Endocrinology (Copenhagen) 129 1993 201-206
33. Bing-You R.G. Denis M.C. Rosen C.J. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3 Calcified Tissue International 52 1993 183-187
34. DeBoer H. Blok G.J. Van Lingen A. et al. Consequences of childhood-onset growth hormone deficiency for adult bone mass Journal of Bone and Mineral Research 9 1994 1319-1326
35. Rosen C.J. Kurland E.S. Vereault D. et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density Journal of Clinical Endocrinology and Metabolism 83 1998 2286-2290
36. Rosen C.J. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications Clinical Chemistry 45 1999 1384-1390
37. Rivadeneira F. Janssen J. Beck T.J. et al. Association of an IGF-I gene promoter polymorphism and hip bone geometry and its influence on the risk of hip fracture: The Rotterdam study Journal of Bone and Mineral Research 18 supplement 2 2003 S20
38. Shinar D.M. Endo N. Halperin D. et al. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone Endocrinology 132 1993 1158-1167
39. Watson P.H. Fraher L.J. Natale B.V. et al. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation Bone 26 2000 221-225
40. Lean J.M. Jagger C.J. Chambers T.J. Chow J.W. Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation American Journal of Physiology 268 1995 E318-E327
41. Efstratiadis A. Genetics of mouse growth International Journal of Developmental Biology 42 7 Special No 1998 955-976
42. Bikle D. Majumdar S. Laib A. et al. The skeletal structure of insulin-like growth factor I-deficient mice Journal of Bone and Mineral Research 16 2001 2320-2329
43. Quaife C.J. Mathews L.S. Pinkert C.A. et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice Endocrinology 124 1989 40-48
44. Mathews L.S. Hammer R.E. Brinster R.L. Palmiter R.D. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth Endocrinology 123 1988 433-437
45. Corsini A. Fantappie S. Granata A. et al. Binding-defective low-density lipoprotein in family with hypercholesterolaemia Lancet 8638 1989 623
46. Gotoda T. Senda M. Gamou T. et al. Nucleotide sequence of human cDNA coding for a lipoprotein lipase (LPL) cloned from placental cDNA library Nucleic Acids Research 17 1989 2351
47. Wolf E. Rapp K. Blum W.F. et al. Skeletal growth of transgenic mice with elevated levels of circulating insulin-like growth factor-II Growth Regulation 5 1995 177-193
48. DeChiara T.M. Efstratiadis A. Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting Nature 345 1990 78-80
49. Beamer W.H. Eicher E.M. Stimulation of growth in the little mouse Journal of Endocrinology 71 1976 37-45
50. Maheshwari H.G. Bouillon R. Baumann G. Normal volumetric density in adults with life long untreated severe growth homrone deficiency due to genetic GHRH receptor deficiency Journal of Bone and Mineral Research 16 supplement 2001 399
51. Ogata N. Chikazu D. Kubota N. et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover Journal of Clinical Investigation 105 2000 935-943
52. Silha J.V. Mishra S. Rosen C.J. et al. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice Journal of Bone and Mineral Research 18 2003 1834-1841
53. Zhang Q. Wastney M.E. Rosen C.J. Weaver C.M. Insulin-like growth factor I (IGF-I) infusion increases bone calcium deposition in the growing rat model Journal of Bone and Mineral Research 16 2001 S356
54. Miyakoshi N. Qin X. Kasukawa Y. et al. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism Endocrinology 142 2001 2641-2648
55. Pintar J.E. Cerro J.A. Wood T.L. Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development Hormone Research 45 1996 172-177
56. Zhao G. Monier-Faugere M.C. Langub M.C. et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation Endocrinology 141 2000 2674-2682
57. Zhang M. Xuan S. Bouxsein M.L. et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization Journal of Biological Chemistry 277 2002 44005-44012
58. Yakar S. Rosen C.J. Beamer W.G. et al. Circulating levels of IGF-1 directly regulate bone growth and density Journal of Clinical Investigation 110 2002 771-781
59. Yakar S. Liu J.L. Stannard B. et al. Normal growth and development in the absence of hepatic insulin-like growth factor I Proceedings of the National Academy of Sciences of the United States of America 96 1999 7324-7329
60. Lupu F. Terwilliger J.D. Lee K. et al. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth Developmental Biology 229 2001 141-162
61. Rosen C.J. Beamer W.G. Donahue L.R. Defining the genetics of osteoporosis: using the mouse to understand man Osteoporosis International 12 2001 803-810
62. Beamer W.G. Shultz K.L. Donahue L.R. et al. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice Journal of Bone and Mineral Research 16 2001 1195-1206
63. Richman C. Kutilek S. Miyakoshi N. et al. Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice Journal of Bone and Mineral Research 16 2001 386-397
64. Bouxsein M.L. Rosen C.J. Turner C.H. et al. Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo Journal of Bone and Mineral Research 17 2002 570-579